Far From Certican: Novartis Hopes REMS Will Tip Balance For Kidney Transplant Drug
FDA's cardio-renal committee will weigh whether a communication-focused risk management plan can assuage concerns about renal toxicity and slow wound healing.
FDA's cardio-renal committee will weigh whether a communication-focused risk management plan can assuage concerns about renal toxicity and slow wound healing.